Companies · Other Health Care

Eye C Better Corp.

INDIO · Other Health Care

Diligence memoA one-page analyst read on Eye C Better Corp. — recommendation, valuation, rhythm, risks.
$955K
Total raised · real
2
Rounds
0.4×
Latest step-up
Top 69%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Eye C Better Corp. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.79× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
  • Issuer reports no revenue, yet is modeled well above niche peers.
Dormant
  • Last raise 4.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Eye C Better Corp. is one of 5377 Other Health Care companies tracked from INDIO. By capital raised it ranks in the long tail (ahead of 32% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 506(b)
Reg D exemption
8
Investors (latest)
2021
Year incorporated
2021-09-27
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2021-09-14 Raised $100K (real) Modeled valuation $1.7M (est)$100K$1.7MPre-Seed2021Pre-Seed · 2021-09-14 Raised $855K (real) Modeled valuation $14M (est)$855K$14MPre-Seed2021Pre-Seed · 2021-09-27 Raised $300K (real) Modeled valuation $5.0M (est)$300K$5.0MPre-Seed2021+$855K+$300KCumulative $1.3M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$100K · 2021
Pre-Seed extension$855K · 2021
Pre-Seed extension$300K · 2021

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$14.5M
Base estimate est.
$536K
Conservative case
$114.1M
Upside case
$4.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $1.7M · 2021-09-142021Pre-Seed · modeled $14.5M · 2021-09-14Pre-Seed · modeled $5.0M · 2021-09-272021
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
4.8 yr
Elapsed time used
4.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
4.8 yr
On record since
2021
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.4× of median
This company$955K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.9× of median
This company$300K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.7× of median
This company$14.5M
Sector median$22.1M

Raised more than 32% of sector peers (real $). Modeled value above 41% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #82 of 295.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Aetas Co LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Hauppauge SC Holdings, LLC · Pre-Seed Raised $995K · modeled $30.6M (est)Gateway IV Lithotripsy, LLC · Pre-Seed Raised $988K · modeled $30.4M (est)Endoscopy Center of West Central Ohio, LLC · Pre-Seed Raised $964K · modeled $29.7M (est)Dalent LLC · Pre-Seed Raised $1.9M · modeled $29.2M (est)FK Investor LLC · Pre-Seed Raised $940K · modeled $29.0M (est)Lynx Dx, Inc. · Pre-Seed Raised $925K · modeled $28.5M (est)Center at Arrowhead, LLC · Pre-Seed Raised $918K · modeled $28.3M (est)MedTek Valencia eCoin, LLC · Pre-Seed Raised $905K · modeled $27.9M (est)Westside PetWell, LLC · Pre-Seed Raised $900K · modeled $27.7M (est)Ulster Dialysis Partners, LLC · Pre-Seed Raised $930K · modeled $27.6M (est)DoveMed, Ltd. · Pre-Seed Raised $1.5M · modeled $26.5M (est)Eye C Better Corp. (this company) Raised $955K · modeled $14.5M (est)Eye C Better Corp.
CompanyStageRaised · realValue · estvs peer med.
Aetas Co LLCPre-Seed$1.0M$30.8M3.80×
Hauppauge SC Holdings, LLCPre-Seed$995K$30.6M3.78×
Gateway IV Lithotripsy, LLCPre-Seed$988K$30.4M3.75×
Endoscopy Center of West Central Ohio, LLCPre-Seed$964K$29.7M3.66×
Dalent LLCPre-Seed$1.9M$29.2M3.61×
FK Investor LLCPre-Seed$940K$29.0M3.57×
Lynx Dx, Inc.Pre-Seed$925K$28.5M3.51×
Center at Arrowhead, LLCPre-Seed$918K$28.3M3.49×
MedTek Valencia eCoin, LLCPre-Seed$905K$27.9M3.44×
Westside PetWell, LLCPre-Seed$900K$27.7M3.42×
Ulster Dialysis Partners, LLCPre-Seed$930K$27.6M3.40×
DoveMed, Ltd.Pre-Seed$1.5M$26.5M3.27×
Eye C Better Corp. this companyPre-Seed$955K$14.5M1.79×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$100K2021-09-14$556K$1.7M90%
Pre-Seed$855K2021-09-14$4.8M$14.5M90%
Pre-Seed$300K2021-09-27$1.7M$5.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$100K2021-09-14
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$855K2021-09-14
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.6× larger than the prior — scaling up.
    • 19 investors on this round.
  3. Pre-Seed$300K2021-09-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× smaller than the prior — bridge or down round.
    • 8 investors on this round.
Intelligence
2021 ~Q4
Modeled next raise · ~0mo cadence
$300K
Modeled next size est.range $300K$480K
0.4×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Chadwick James Wasilenkoff2021-09
Joel Molina Solano2021-09
Registry & provenance

Eye C Better Corp. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1884453
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Hubble Telemedical Inc.Other Health CarePre-Seed$950K$12.3Msame sector · same stage
Hawthorn Place Outpatient Surgery Center L POther Health CarePre-Seed$964K$14.5Msame sector · same stage
LivOnyx Inc.Other Health CarePre-Seed$945K$14.0Msame sector · same stage
Imagen Walled Lake Support Services, LLCOther Health CarePre-Seed$977K$12.9Msame sector · same stage
BSC Chandler LLCOther Health CarePre-Seed$980K$16.3Msame sector · same stage
Choix, Inc.Other Health CarePre-Seed$1000K$12.2Msame sector · same stage
Active Recovery TMS, LLCOther Health CarePre-Seed$1.0M$14.1Msame sector · same stage
Dallas Expansion Clinic, LPOther Health CarePre-Seed$1.0M$15.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Eyecheq Inc.Other Health CareSeed$18.7M88%
Network Eye, Inc.Other Health CareSeries A$77.6M86%
CEI Vision Partners Holdings, LLCOther Health CareSeed$34.0M85%
Better Management Holdings, LLCOther Health CareSeries A$22.9M85%
Eyenuk, Inc.Other Health CareSeries B$262.8M85%
American Vision Partners Holdings CorpOther Health CarePre-Seed$25.0M84%
Eyevensys S.A.S.Other Health CareSeries A$136.8M84%
Connecticut Vision Holdings, LLCOther Health CareSeed$25.4M84%
Frequently asked
How much funding has Eye C Better Corp. raised?
Eye C Better Corp. has raised approximately $955K in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Eye C Better Corp.'s estimated valuation?
Provath's modeled valuation for Eye C Better Corp. is approximately $14.5M (modeled range $536K–$114.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Eye C Better Corp. at?
Eye C Better Corp.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue Sep 14.
What does Eye C Better Corp. do and where is it based?
Eye C Better Corp. operates in the Other Health Care sector, based in INDIO.
Explore related

See where Eye C Better Corp. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Eye C Better Corp., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.